PSA (Prostate-Specific Antigen) vs Stroke Treatment (Acute)
Medicare Cost Comparison 2025
Quick Answer
PSA (Prostate-Specific Antigen): $40 total · Medicare pays $32 · Patient pays $8
Stroke Treatment (Acute): $20,000 total · Medicare pays $16,000 · Patient pays $4,000
Cost Comparison
| Metric | PSA (Prostate-Specific Antigen) | Stroke Treatment (Acute) |
|---|---|---|
| Total Average Cost | $40 | $20,000 |
| Medicare Pays | $32 | $16,000 |
| Patient Pays | $8 | $4,000 |
| Category | lab | hospital |
FAQ
What is the cost difference between PSA (Prostate-Specific Antigen) and Stroke Treatment (Acute)?
Stroke Treatment (Acute) costs $20,000 on average, while PSA (Prostate-Specific Antigen) costs $40 — a difference of $19,960.
How much does Medicare pay for PSA (Prostate-Specific Antigen) vs Stroke Treatment (Acute)?
Medicare typically pays $32 for PSA (Prostate-Specific Antigen) (patient owes $8). For Stroke Treatment (Acute), Medicare pays $16,000 (patient owes $4,000).
What is PSA (Prostate-Specific Antigen)?
Blood test for prostate cancer screening.
What is Stroke Treatment (Acute)?
Emergency hospital treatment for acute stroke including thrombolytics.